{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01078805","recordId":"NCT01078805","peptideSlug":"teriparatide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01078805-teriparatide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01078805.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01078805.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2010-03-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"teriparatide","submittedDate":"2010-03-01","publishedAt":"2026-08-23","recordId":"NCT01078805","recordSha256":"34f2968a27d19b2b5cf82fbdb5bae76757910b64d575598ea91a93872796b891","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01078805?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2011-02-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"teriparatide","submittedDate":"2011-02-22","publishedAt":"2026-08-23","recordId":"NCT01078805","recordSha256":"177f039486eaf510b2223b3ef30dd0c22e2112a0b0020c6f36a38d2ab93ca16e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01078805?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Sponsor/Collaborators","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2012-05-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"teriparatide","submittedDate":"2012-05-16","publishedAt":"2026-08-23","recordId":"NCT01078805","recordSha256":"5945d9f4182252c2329cf1fba8d942acd28f68b3e5ee2d189dbc07d261dc4721","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01078805?a=3&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"d9be1607da010a5a20fbd5d873389cdff9510680d8eaa69b6f1b073e0b766310"}}